
Jacqueline Tamis-Holland, MD

-
- Positions
- ASSOCIATE PROFESSOR | Medicine, Cardiology
- ASSOCIATE PROFESSOR | Medical Education
-
- Specialties
- Cardiovascular Disease
- Interventional Cardiology
-
- Language
- English
-
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
-
- Phone
- Mount Sinai Morningside 212-523-2400 212-523-2400
A graduate of New York University School of Medicine, Dr. Tamis-Holland completed her Internal Medicine training at NYU School of Medicine and her Cardiology and Interventional Cardiology Fellowship training at Saint Luke’s-Roosevelt Hospital Center and Columbia University.
After her fellowship training Dr. Tamis-Holland joined the cardiology staff of St. Lukes-Roosevelt Hospital (now Mount Sinai Morningside and Mount Sinai West) where she served as Site Director of the Roosevelt Hospital Cardiac Catheterization Laboratory and Associate Director of the Mount Sinai Saint Luke’s Cardiac Catheterization laboratory before assuming her current position.
Dr. Tamis-Holland is a member of the American College of Cardiology-American Heart Association’s Joint Committee for Clinical Practice Guidelines and a member of the New York State Cardiac Advisory Committee. She is Vice Chair of the writing committee for the American College of Cardiology-American Heart Association’s Guidelines for Coronary Revascularization and on the editorial board for Circulation Cardiovascular Intervention. She is the Chair of the Academic Council of the American College of Cardiology and the immediate past Chair of the Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology for the American Heart Association. Dr Tamis Holland was on the rating panel for the 2016 Appropriate Use Criteria for Coronary Revascularization in Acute Coronary Syndromes and the 2017 Appropriate Use Criteria for Stable Ischemic Heart Disease
Dr Tamis-Holland’s clinical and research interests focus on the treatment of patients with Acute ST Elevation Infarction. She is co-author of the 2013 American College of Cardiology-American Heart Association’s Guidelines for ST Segment Elevation Infarction and the 2015 Focused Update for PCI in ST Segment Elevation Infarction. She also worked on the executive committee for the Mission Lifeline STEMI Accelerator Program in NYC focusing on improving systems of care for patients with STEMI in New York City. Her work led to the creation of protocols providing an integrated relationship between the NYC EMS and the cardiac catheterization laboratories in the NYC PCI hospitals. Dr Tamis-Holland is nationally known for her work in treating patients with STEMI and has lectured extensively at national and international meetings. She has over 100 peer-reviewed medical articles, book chapters and medical editorials, some of which are considered seminal contributions to the fields of Cardiology.
Dr Tamis Holland is a devoted teacher, educator and volunteer. She is the proud recipient of the “Michael Lesch Teaching Award in Cardiology”, as well as the American Heart Association’s “Luminary with Heart” award and the American Heart Association’s “Heart of Our Mission” award.
Certifications
Interventional Cardiology
Cardiovascular Disease
Clinical Focus
- Acute Coronary Syndrome
- Angiography
- Cardiac Catherization
- Cardiomyopathy
- Cardiovascular Disease
- Coronary Angioplasty
- Heart Attack/Acute Coronary Syndrome
- Valvular Heart Disease
Education
MD, New York University School of Medicine
Residency, Internal Medicine
Bellevue Hospital Center
Fellowship, Cardiology
Henry Ford Medical Group
Fellowship, Interventional Cardiology
Henry Ford Medical Group
Language
English
Download the CV
2014
Luminary of the Heart, American Heart Association, Go Red for Women NYC
2014
American Heart Association, Heart of Our Mission Volunteer Award
Her research interests include acute coronary syndromes, and women and heart disease.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Tamis-Holland during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Medscape
- New York State Department of Health (NYSDOH)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.